Relation between diastolic left ventricular function and myocardial blood volume during adenosine-induced coronary hyperemia. 1995

J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
Philadelphia Heart Institute, Presbyterian Medical Center, PA 19104.

Adenosine infusion is accompanied by increases in coronary blood flow and myocardial blood volume. Myocardial blood volume may produce changes in diastolic left ventricular (LV) performance by increasing myocardial turgor. Diastolic dysfunction may also be the result of myocardial ischemia. The relation between changes in LV mass and diastolic function has not been previously investigated. This study examined the relation between changes in LV mass during adenosine-induced coronary hyperemia and LV diastolic function. Serial two-dimensional and Doppler echocardiographic measurements were made before, during, and after adenosine infusion (140 micrograms/min for 6 min) in 21 patients with (group 1) and 10 patients without (group 2) coronary artery disease (CAD). The LV mass and transmitral diastolic filling indexes were determined from digitized images from apical four-chamber view. Adenosine infusion produced a greater increase in LV mass in group 2 than in group 1 (29% +/- 11% vs 9% +/- 6%, p < 0.0002). The ratio of transmitral early (E) to atrial (A) filling velocity (E/A) increased 10% +/- 16% in group 2 and decreased 8% +/- 20% in group 1 (p < 0.02), and the velocity time integral of early filling increased 11% +/- 52% in group 2 and decreased 20% +/- 31% in group 1 (p < 0.04). There was a correlation between the change in E/A ratio and the LV mass (r = 0.53, p < 0.003). Thus adenosine infusion caused a greater increase in LV mass in normal subjects than in patients with CAD. There were also changes in Doppler-derived indexes of diastolic LV function.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003971 Diastole Post-systolic relaxation of the HEART, especially the HEART VENTRICLES. Diastoles
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
June 1997, The American journal of cardiology,
J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
October 1992, British heart journal,
J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
April 2017, Circulation. Cardiovascular interventions,
J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
May 2001, Coronary artery disease,
J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
January 2004, Toxicology mechanisms and methods,
J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
January 1986, Catheterization and cardiovascular diagnosis,
J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
July 2001, The American journal of cardiology,
J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
May 1988, Aviation, space, and environmental medicine,
J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
December 2006, Current heart failure reports,
J F Ren, and S B Pancholy, and J G Kegel, and G W Lighty, and J Heo, and A S Iskandrian
August 1995, Circulation,
Copied contents to your clipboard!